# reload+after+2024-01-23 20:46:52.799653
address1§Building 1
address2§900 Middlesex Turnpike
city§Billerica
state§MA
zip§01821
country§United States
phone§617-301-9400
website§https://www.quanterix.com
industry§Medical Devices
sector§Healthcare
longBusinessSummary§Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables, such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, custom development, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
fullTimeEmployees§370
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Masoud  Toloue Ph.D.', 'age': 42, 'title': 'President, CEO & Director', 'yearBorn': 1981, 'fiscalYear': 2022, 'totalPay': 957030, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. David R. Walt Ph.D.', 'age': 70, 'title': 'Co-Founder, Chairman of Scientific Advisory Board & Independent Director', 'yearBorn': 1953, 'fiscalYear': 2022, 'totalPay': 47250, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Mark T. Roskey Ph.D.', 'age': 63, 'title': 'Senior Vice President of Strategic Partnerships', 'yearBorn': 1960, 'fiscalYear': 2022, 'totalPay': 495028, 'exercisedValue': 845132, 'unexercisedValue': 275288}, {'maxAge': 1, 'name': 'Mr. Michael A. Doyle', 'age': 67, 'title': 'Executive Director of Finance', 'yearBorn': 1956, 'fiscalYear': 2022, 'totalPay': 570145, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Vandana  Sriram CPA', 'age': 49, 'title': 'Chief Financial Officer', 'yearBorn': 1974, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Daniel  Pikora', 'age': 47, 'title': 'Chief Operating Officer', 'yearBorn': 1976, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. David C. Duffy Ph.D.', 'age': 52, 'title': 'Senior VP of Research & Development and CTO', 'yearBorn': 1971, 'fiscalYear': 2022, 'totalPay': 299051, 'exercisedValue': 0, 'unexercisedValue': 1554586}, {'maxAge': 1, 'name': 'Ms. Alexandra  Phillips', 'title': 'Senior VP & Chief Information Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Laurie A. Churchill', 'age': 52, 'title': 'Senior VP, General Counsel & Secretary', 'yearBorn': 1971, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'David  Panzerella', 'title': 'Vice President of Sales', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§9
boardRisk§10
compensationRisk§6
shareHolderRightsRisk§8
overallRisk§9
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.34
priceToSalesTrailing12Months§8.292871
currency§USD
dateShortInterest§1702598400
forwardEps§-1.03
exchange§NGM
quoteType§EQUITY
shortName§Quanterix Corporation
longName§Quanterix Corporation
firstTradeDateEpochUtc§1512657000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§8e20e2ff-7558-397a-8c05-8f7125a41749
gmtOffSetMilliseconds§-18000000
targetHighPrice§35.0
targetLowPrice§31.0
targetMeanPrice§33.25
targetMedianPrice§33.5
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§4
quickRatio§10.007
grossMargins§0.56959
ebitdaMargins§-0.33009997
trailingPegRatio§None
